Cargando…
Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress model
Introduction: This study aims to further characterize cannabidiol’s pharmacological and molecular profile as an antidepressant. Methods: Effects of cannabidiol (CBD), alone or combined with sertraline (STR), were evaluated in male CD1 mice (n = 48) exposed to an unpredictable chronic mild stress (UC...
Autores principales: | García-Gutiérrez, María Salud, Navarro, Daniela, Austrich-Olivares, Amaya, Manzanares, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151764/ https://www.ncbi.nlm.nih.gov/pubmed/37144214 http://dx.doi.org/10.3389/fphar.2023.1171646 |
Ejemplares similares
-
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021) -
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
por: Austrich-Olivares, Amaya, et al.
Publicado: (2022) -
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
por: García-Gutiérrez, María S., et al.
Publicado: (2020) -
Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation
por: Camacho, Mariam B., et al.
Publicado: (2017) -
Cannabis Use in Pregnant and Breastfeeding Women: Behavioral and Neurobiological Consequences
por: Navarrete, Francisco, et al.
Publicado: (2020)